Skip to main navigation Skip to search Skip to main content

A 12-Week, Mulicenter, Open-Label Extension Study in Subjects with Schizophrenia

Project: Research

Project Details

StatusFinished
Effective start/end date05/24/12 → 05/24/16

Funding

  • Sunovion Pharmaceuticals Incorporated: $8,602.90